Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0KATRZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
FI3789042T3Antibody-drug conjugate (10)
|
|||||
| Synonyms |
FI3789042T3Antibody-drug conjugate (10)
Click to Show/Hide
|
|||||
| Organization |
DAIICHI SNAKYO COMPANY,LIMITED
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
6.2
|
|||||
| Antibody Name |
U1-59
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-3 (ERBB3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Antibody-drug conjugate (9)Linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
ADC-specific functional property(2027 Update)
Binding Affinity
| Dissocation Constant (Kd) | Binding Target | Description | Reference |
|---|---|---|---|
| 1.554 nM |
Receptor tyrosine-protein kinase erbB-3 (ERBB3)
|
Exhibited average binding affinity KD EQUIVALENT TO NON-CONJUGATED ANTI her3 ANTIBODY u1-59.
|
[1]
|